You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: RE39071


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE39071
Title:Anhydro-and isomer-a-21978c cyclic peptides
Abstract:Two new groups of A-21978C cyclic peptides, anhydro- and isomer-A21978C peptide derivatives, have antibacterial activity and are useful as intermediates. The two groups are prepared via transpeptidation of the parent cyclic peptides. Pharmaceutical formulations containing the new peptides as active ingredients and methods of treating infections caused by susceptible Gram-positive bacteria with the formulations are also provided.The invention also provides an antibacterial composition containing the new drug substance LY 146032 in substantially pure form.
Inventor(s): Baker; Patrick J. (Greenwood, IN), Debono; Manuel (Indianapolis, IN), Farid; Khadiga Z. (Lebanon, IN), Molloy; R. Michael (Avon, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:09/547,357
Patent Claim Types:
see list of patent claims
Compound; Use; Composition; Formulation; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis

Introduction

When navigating the complex landscape of U.S. patents, understanding the scope and claims of a patent is crucial for inventors, patent applicants, and legal professionals. This article will delve into the key aspects of patent scope and claims, using the context of a reissued patent like U.S. Patent RE39071 as a framework for discussion.

What are Patent Claims?

Patent claims are the legal definitions of the invention, outlining what the inventor considers to be their invention and what they seek to protect. These claims are the heart of a patent application and must be carefully crafted to ensure they are valid, enforceable, and aligned with the invention described in the specification[5].

Importance of Claim Scope

The scope of a patent claim is a delicate balance between breadth and specificity. A broader claim scope can offer more comprehensive protection but is often more challenging to obtain and more susceptible to invalidation. Conversely, narrower claims are easier to get granted but may not provide the desired level of protection[5].

Metrics for Measuring Patent Scope

Researchers have identified simple yet effective metrics to measure patent scope, including independent claim length and independent claim count. These metrics have been validated by their explanatory power for various correlates of patent scope, such as patent maintenance payments, forward citations, and the breadth of patent classes. Studies show that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

The Risks of Overly Broad Claims

Overly broad claims can lead to several issues, including increased difficulty in getting the patent granted and a higher risk of invalidation. Two common grounds for invalidating broad claims are the abstract idea exception and failure to meet the written description requirement. The abstract idea exception, as outlined in the Alice v. CLS Bank decision, ensures that patents do not preempt abstract ideas, which could grant a monopoly over basic concepts rather than specific innovations[5].

The Role of the Written Description Requirement

The written description requirement, under 35 U.S.C. § 112, mandates that the specification must clearly and unequivocally describe the invention as claimed. This requirement is crucial in reissue patents, where the claims must be anchored to the embodiments disclosed in the original patent. For example, in In Re FLOAT'N'GRILL LLC, the Federal Circuit affirmed the rejection of reissue claims because they did not cover the invention disclosed in the original patent[2].

Obviousness-Type Double Patenting (ODP)

ODP is another critical aspect that affects the scope and validity of patent claims. This doctrine prevents the extension of patent term by claiming obvious variations of an invention already patented. In cases like In re Cellect LLC, the Federal Circuit upheld the invalidation of claims under ODP, emphasizing that such analyses must consider the adjusted expiration date of the patent, including any Patent Term Adjustment (PTA)[1].

Reissue Patents and Claim Scope

Reissue patents allow for the broadening or narrowing of claims after the original patent has been granted. However, reissue claims must strictly adhere to the invention disclosed in the original patent. Any attempt to broaden claims to cover undisclosed alternatives or essential features not explicitly described in the original specification can lead to invalidation, as seen in In Re FLOAT'N'GRILL LLC[2].

Practical Considerations for Drafting Claims

When drafting patent claims, several factors must be considered:

  • Invention Details: Claims must be anchored to the specific embodiments described in the specification.
  • Prior Art: The level of prior art in the technical field can affect the breadth of claims that can be allowed.
  • Client’s Budget: Broader claims are often more costly to prosecute and maintain.
  • Technical Field: The nature of the technical field can influence the appropriate scope of claims[5].

Case Studies and Lessons

Recent court decisions, such as Yu v. Apple Inc. and Minerva Surgical, Inc. v. Hologic, Inc., provide valuable lessons on the importance of proper claim scope. These cases highlight the risks of broadening claims too far, which can lead to invalidation under the abstract idea exception or failure to meet the written description requirement[5].

Key Takeaways

  • Balanced Claim Scope: The scope of patent claims must be balanced between breadth and specificity.
  • Metrics for Scope: Independent claim length and count are useful metrics for measuring patent scope.
  • Risks of Broad Claims: Overly broad claims are more difficult to get granted and are at a higher risk of invalidation.
  • Written Description Requirement: Claims must be clearly and unequivocally described in the specification.
  • ODP Considerations: ODP analyses are crucial in preventing the extension of patent term through obvious variations.
  • Reissue Patent Limitations: Reissue claims must adhere strictly to the invention disclosed in the original patent.

FAQs

Q1: What is the importance of claim scope in a U.S. patent application? The claim scope is crucial as it defines the legal boundaries of the invention. A balanced scope ensures that the patent is both enforceable and valid.

Q2: How do overly broad claims affect the patent application process? Overly broad claims are more difficult to get granted and are at a higher risk of invalidation due to grounds such as the abstract idea exception and failure to meet the written description requirement.

Q3: What metrics can be used to measure patent scope? Independent claim length and independent claim count are simple yet effective metrics for measuring patent scope.

Q4: Can reissue claims broaden the scope of the original patent? Reissue claims must strictly adhere to the invention disclosed in the original patent and cannot broaden the scope to cover undisclosed alternatives or essential features not explicitly described.

Q5: Why is the written description requirement important in patent claims? The written description requirement ensures that the claims are clearly and unequivocally described in the specification, which is essential for the validity and enforceability of the patent.

Sources

  1. In re Cellect LLC, United States Court of Appeals for the Federal Circuit, 2023.
  2. In Re FLOAT'N'GRILL LLC, United States Court of Appeals for the Federal Circuit, 2023.
  3. Patent Claims and Patent Scope, SSRN, 2016.
  4. US-RE33177-E - In Place Gas Cleaning of Diffusion Elements, Unified Patents.
  5. The Importance of Getting the Claim Scope Right in a US Patent Application, Rimon Law, 2021.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE39071

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.